Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

Have you been diagnosed with Metastatic Neuroendocrine Tumors or Pancreatic Cancer? If so then you may be a good fit for a clinical trial that evaluates the length of time cancer is not growing, or spreading) in participants when treated with zanzalintinib compared to everolimus.

Have you been diagnosed with Gastric Cancer? If so, you might be able to take part in a study to see if an investigational product is safe and effective for treating Gastric Cancer.

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

The purpose of this study is to see at what doses of etentamig combined with Iberdomide is better tolerated and safe for patients with relapsed/refractory multiple myeloma.

Join our study for people with breast cancer that may have spread to other parts of the body. You'll help us learn how exercise can help others with cancer feel better. You'll join a free 16-week exercise program. You'll fill out simple surveys and do some activity checks at the start and end.

Do you have leukemia, lymphoma, MDS, or MF and are preparing for a stem cell transplant from an unrelated donor? If so, you might be eligible to take part in a study that will look look at combinations of medicines given after a stem cell transplant and see how well the combinations work to prevent graft versus host disease and infection.

Do you have metastatic HER2-positive breast cancer? if so you may be able to participate in this research study to find out whether zanidatamab combined with chemotherapy of study doctor's choice is safe and improves on the clinical benefit when compared to trastuzumab in combination with chemotherapy of study doctor's choice in treating the type of breast cancer you have.

Do you have cancer that's been hard to treat? You might be eligible to join a study to try a new medicine. This study looks at how well it works and how safe it is. You can help us find new ways to fight cancer!

Have you been previously treated for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)? If so, you may be able to take part in a research study to determine if BGB-16673 and pirtobrutinib can be used to treat patients with previously treated CLL or SLL.